Endothelial progenitor cells for postnatal vasculogenesis
- PMID: 15308462
- DOI: 10.1152/ajpcell.00330.2003
Endothelial progenitor cells for postnatal vasculogenesis
Abstract
In the past decade, researchers have defined committed stem or progenitor cells from various tissues, including bone marrow, peripheral blood, brain, liver, and reproductive organs, in both adult animals and humans. Whereas most cells in adult organs are composed of differentiated cells, which express a variety of specific phenotypic genes adapted to each organ's environment, quiescent stem or progenitor cells are maintained locally or in the systemic circulation and are activated by environmental stimuli for physiological and pathological tissue regeneration. Recently, endothelial progenitor cells (EPCs) were isolated from peripheral blood CD34, Flk-1, or AC133 antigen-positive cells, which are considered to include a hematopoietic stem cell population, and were shown to be incorporated into foci of neovascularization. This finding, that circulating EPCs may home to sites of neovascularization and differentiate into endothelial cells in situ, is consistent with "vasculogenesis," a critical paradigm for embryonic neovascularization, and suggests that vasculogenesis and angiogenesis may constitute complementary mechanisms for postnatal neovascularization. Previous reports demonstrating therapeutic potential of EPC transplantation in animal models of hindlimb and myocardial ischemia opened the way to the clinical application of cell therapy: the replacement of diseased or degenerating cell populations, tissues, and organs. In this review, we summarize biological features of EPCs and speculate on the utility of EPCs for vascular and general medicine.
Similar articles
-
Therapeutic potential of endothelial progenitor cells for cardiovascular diseases.Curr Vasc Pharmacol. 2006 Jan;4(1):59-65. doi: 10.2174/157016106775203063. Curr Vasc Pharmacol. 2006. PMID: 16472177 Review.
-
Angiogenesis and vasculogenesis for therapeutic neovascularization.Nagoya J Med Sci. 2003 May;66(1-2):1-7. Nagoya J Med Sci. 2003. PMID: 12848416 Review.
-
Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization.Circ Res. 1999 Aug 6;85(3):221-8. doi: 10.1161/01.res.85.3.221. Circ Res. 1999. PMID: 10436164
-
Cell therapy and gene therapy using endothelial progenitor cells for vascular regeneration.Handb Exp Pharmacol. 2007;(180):181-94. doi: 10.1007/978-3-540-68976-8_8. Handb Exp Pharmacol. 2007. PMID: 17554509 Review.
-
[Vascular regeneration].Nihon Rinsho. 2008 May;66(5):899-907. Nihon Rinsho. 2008. PMID: 18464508 Review. Japanese.
Cited by
-
A nanobiosensor for dynamic single cell analysis during microvascular self-organization.Nanoscale. 2016 Oct 14;8(38):16894-901. doi: 10.1039/c6nr03907c. Epub 2016 Aug 22. Nanoscale. 2016. PMID: 27547924 Free PMC article.
-
Leukocyte-mimicking stem cell delivery via in situ coating of cells with a bioactive hyperbranched polyglycerol.J Am Chem Soc. 2013 Jun 19;135(24):8770-3. doi: 10.1021/ja400636d. Epub 2013 Apr 19. J Am Chem Soc. 2013. PMID: 23590123 Free PMC article.
-
Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus.Arthritis Res Ther. 2007;9(4):R84. doi: 10.1186/ar2283. Arthritis Res Ther. 2007. PMID: 17764548 Free PMC article.
-
Mechanisms of disease: pulmonary arterial hypertension.Nat Rev Cardiol. 2011 Jun 21;8(8):443-55. doi: 10.1038/nrcardio.2011.87. Nat Rev Cardiol. 2011. PMID: 21691314 Free PMC article. Review.
-
Effects of acute and chronic endurance exercise on intracellular nitric oxide and superoxide in circulating CD34⁺ and CD34⁻ cells.J Appl Physiol (1985). 2011 Sep;111(3):929-37. doi: 10.1152/japplphysiol.00541.2011. Epub 2011 Jun 23. J Appl Physiol (1985). 2011. PMID: 21700895 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous